Data entered in these fields is not covered by PCI DSS compliance.
This product is intended only to be used as a laboratory solvent for reconstituting research chemicals
The United States Pharmacopeial Convention (USP) Dietary Supplements Information Expert Committee (DSI-EC) reviewed clinical, preclinical, and regulatory data, including adverse event reports, and assigned Spirulina maxima and Spirulina platensis a Class A safety rating, permitting the development of quality monographs in the USPNF (119)
Further studies are needed to confirm the results
Systemic Effects Beyond local reactions, some participants in aod 9604 peptide studies report systemic effects: Mild Headaches : Occurring in approximately 5-8% of research subjects, these typically resolve within hours and may be related to initial adaptation to the peptide
The twenty-six week completion rate in Study 2 was 74%